Company Info
Year Established2016
Ticker
VIR
Exchange
NASDAQ
Contacts
Marianne De Backer, MSc, Ph.D., MBACEO
Sung Lee
CFO
Aine Hanly, Ph.D.
CTO
Johanna Friedl-Naderer
COO
Jeff Calcagno, M.D.
CBO
Vanina de Verneuil, J.D
CLO
Company Description
Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.